1. Home
  2. MNOV vs GAN Comparison

MNOV vs GAN Comparison

Compare MNOV & GAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNOV
  • GAN
  • Stock Information
  • Founded
  • MNOV 2000
  • GAN 1999
  • Country
  • MNOV United States
  • GAN United States
  • Employees
  • MNOV N/A
  • GAN N/A
  • Industry
  • MNOV Biotechnology: Pharmaceutical Preparations
  • GAN Computer Software: Programming Data Processing
  • Sector
  • MNOV Health Care
  • GAN Technology
  • Exchange
  • MNOV Nasdaq
  • GAN Nasdaq
  • Market Cap
  • MNOV 91.7M
  • GAN 83.2M
  • IPO Year
  • MNOV 2005
  • GAN 2020
  • Fundamental
  • Price
  • MNOV $1.90
  • GAN $1.83
  • Analyst Decision
  • MNOV Strong Buy
  • GAN
  • Analyst Count
  • MNOV 1
  • GAN 0
  • Target Price
  • MNOV $9.00
  • GAN N/A
  • AVG Volume (30 Days)
  • MNOV 21.3K
  • GAN 233.8K
  • Earning Date
  • MNOV 02-18-2025
  • GAN 03-12-2025
  • Dividend Yield
  • MNOV N/A
  • GAN N/A
  • EPS Growth
  • MNOV N/A
  • GAN N/A
  • EPS
  • MNOV N/A
  • GAN N/A
  • Revenue
  • MNOV N/A
  • GAN $134,024,000.00
  • Revenue This Year
  • MNOV N/A
  • GAN $5.97
  • Revenue Next Year
  • MNOV N/A
  • GAN $11.32
  • P/E Ratio
  • MNOV N/A
  • GAN N/A
  • Revenue Growth
  • MNOV N/A
  • GAN N/A
  • 52 Week Low
  • MNOV $1.12
  • GAN $1.17
  • 52 Week High
  • MNOV $2.55
  • GAN $1.90
  • Technical
  • Relative Strength Index (RSI)
  • MNOV 45.15
  • GAN 36.63
  • Support Level
  • MNOV $1.87
  • GAN $1.72
  • Resistance Level
  • MNOV $2.06
  • GAN $1.85
  • Average True Range (ATR)
  • MNOV 0.08
  • GAN 0.03
  • MACD
  • MNOV 0.00
  • GAN -0.01
  • Stochastic Oscillator
  • MNOV 47.48
  • GAN 38.89

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

About GAN GAN Limited

GAN Ltd provides Software-as-a-Service solutions for online casino gaming and sports betting applications. The company has two operating segments B2B and B2C. The B2B segment develops, markets, and sells instances of GameSTACK, GAN Sports, and iSight Back Office technology that incorporates comprehensive player registration, account funding, and back-office accounting and management tools that enable the casino operators to efficiently, confidently, and effectively extend their presence online in places that have permitted online real money gaming, and The B2C segment, which includes the operations of Coolbet, develops and operates a B2C online sports betting and casino platform that is accessible through its website in markets across Northern Europe, Latin America, and Canada.

Share on Social Networks: